Business

BioMar preliminary financial outlook for 2026 and mid-term targets

BioMar preliminary financial outlook for 2026 and mid-term targets On 12 November 2024, the Board of Directors of Schouw & Co. announced the initiation of an evaluation regarding a potential separate listing of BioMar. The objective of this assessment is to determine whether such a listing would generate added value for Schouw & Co. and its shareholders, while simultaneously ensuring that BioMar is well positioned to pursue opportunities for continued growth. The evaluation is progressing as exp

Schouw & Co A/sDecember 1, 20252
BioMar preliminary financial outlook for 2026 and mid-term targets

About this update from Schouw & Co A/s

BioMar preliminary financial outlook for 2026 and mid-term targets On 12 November 2024, the Board of Directors of Schouw & Co. announced the initiation of an evaluation regarding a potential separate listing of BioMar. The objective of this assessment is to determine whether such a listing would generate added value for Schouw & Co. and its shareholders, while simultaneously ensuring that BioMar is well positioned to pursue opportunities for continued growth. The evaluation is progressing as expected. Schouw & Co. is assisted by a syndicate comprising four financial institutions: DNB Carnegie and Morgan Stanley as Lead Joint Global Coordinators, and Danske Bank and Nordea as Joint Global Coordinators. FIH Partners acts as independent IPO advisor to Schouw & Co. and BioMar. As part of the preparation towards a potential separate listing of BioMar on Nasdaq Copenhagen, which could take place in the first half of 2026, the Board of Directors of Schouw & Co. has evaluated BioMar’s short-term and mid-term outlook and has decided to disclose selected preliminary information. 'Towards 2030, BioMar aims to achieve a volume growth of an average of 4-6% per annum while EBIT is targeted to grow at an average rate of 8-10% per annum. ROIC incl. goodwill is targeted to be above 20%. As a potentially independently listed company, BioMar targets a capital structure in the range of 1.0-2.0 times net interest-bearing debt to EBITDA and a dividend policy aiming for a payout of at least 50% of annual net profit. All the above-mentioned figures are preliminary and subject to change. Schouw & Co. releases its annual report for 2025 on 5 March 2026, in which the outlook for Schouw & Co. and the remaining portfolio companies will be disclosed. Aktieselskabet Schouw & Co. Jørgen Dencker Wisborg, Chairman Jens Bjerg Sørensen, President, tel. +45 8611 22 22 Attachment

View stock analysis, news, and events for Schouw & Co A/s

BioMarSchouw & Co.financial institutionsthe Board of Directors of Schouw & Co.Lead Joint Global CoordinatorsMorgan StanleyJoint Global CoordinatorsDanske Banktargets

More from Schouw & Co A/s

All Schouw & Co A/s news →